Quit smoking and Ventricular fibrillation

Summary:

Ventricular fibrillation is found among people with Quit smoking, especially for people who are female, 40-49 old.

The study analyzes which people have Ventricular fibrillation with Quit smoking. It is created by eHealthMe based on reports of 29 people who have Quit smoking from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Quit smoking?

Quit smoking is found to be associated with 406 drugs and 937 conditions by eHealthMe. Check the latest studies of Quit smoking.

What is Ventricular fibrillation?

Ventricular fibrillation (abnormally irregular heart rhythm) is found to be associated with 1,099 drugs and 1,245 conditions by eHealthMe. Check the latest studies of Ventricular fibrillation.



On Jul, 09, 2026

29 people who have Quit Smoking and Ventricular Fibrillation are studied.

Would you have Ventricular fibrillation when you have Quit smoking?

Gender of people who have Quit Smoking and experienced Ventricular Fibrillation *:

  • female: 57.14 %
  • male: 42.86 %

Age of people who have Quit Smoking and experienced Ventricular Fibrillation *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 20 %
  • 30-39: 30 %
  • 40-49: 30 %
  • 50-59: 10 %
  • 60+: 10 %

Common co-existing conditions for these people *:

  1. Birth Control: 7 people, 24.14%
  2. Hyperlipidaemia (presence of excess lipids in the blood): 6 people, 20.69%
  3. Drug Dependence: 2 people, 6.90%
  4. Ventricular Arrhythmia (problem with the rate or rhythm of the heartbeat): 1 person, 3.45%
  5. Stress And Anxiety: 1 person, 3.45%
  6. Staphylococcal Sepsis (blood infection by an infection with staphylococcus bacteria): 1 person, 3.45%
  7. Rectal Cancer (cancer of rectum): 1 person, 3.45%
  8. Ill-Defined Disorder: 1 person, 3.45%
  9. Device Related Infection: 1 person, 3.45%
  10. Depression: 1 person, 3.45%

Common drugs taken by these people *:

  1. Lisinopril: 8 people, 27.59%
  2. Lovastatin: 7 people, 24.14%
  3. Habitrol: 7 people, 24.14%
  4. Ortho Evra: 7 people, 24.14%
  5. Plavix: 7 people, 24.14%
  6. Toprol-Xl: 7 people, 24.14%
  7. Chantix: 6 people, 20.69%
  8. Varenicline Tartrate: 5 people, 17.24%
  9. Ketalar: 2 people, 6.90%
  10. Diprivan: 2 people, 6.90%

Common symptoms for these people *:

  1. Cardiac Arrest: 16 people, 55.17%
  2. Acute Myocardial Infarction (acute heart attack): 9 people, 31.03%
  3. Chest Pain: 7 people, 24.14%
  4. Venous Thrombosis Limb (blood clot that forms in a vein in the limb): 7 people, 24.14%
  5. Intracardiac Thrombus (presence of a circumscribed mass with heart wall): 7 people, 24.14%
  6. Muscle Contractions Involuntary (uncontrolled muscle contraction): 6 people, 20.69%
  7. Dyspnea (difficult or laboured breathing): 4 people, 13.79%
  8. Consciousness - Decreased: 4 people, 13.79%
  9. Bradycardia (abnormally slow heart action): 4 people, 13.79%
  10. Cardiovascular Insufficiency (inadequate functioning of heart): 4 people, 13.79%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Ventricular fibrillation?

- Check whether Ventricular fibrillation is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Ventricular fibrillation:

All the conditions that are associated with Ventricular fibrillation:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Ventricular fibrillation and Quit smoking, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: